“The historic U.N. Political Declaration to End TB protected worldwide commitments to put us on track to finally ending TB. We require to develop on the increased global awareness and scientific advances in brand-new TB diagnostics, treatments and prevention methods. Now is the time for countries, including the U.S., to redouble efforts to remove TB.
The WHO report finds that TB stays the leading international infectious disease killer. WHO’s information shows that while TB deaths decreased somewhat, from 1.6 million in 2017 to 1.5 million in 2018, the number of new TB cases stayed constant at about 10 million in both 2017 and 2018. On drug resistant TB (DR), WHO reports a small improvement in detection and treatment initiation, with one in three of the approximately half a million people with DR-TB enrolled in treatment in 2018, up from one in four enrolled in treatment in 2017.
Following today’s release of the World Health Organization’s Global Tuberculosis Report 2019, the American Thoracic Society joins the WHO in calling for redoubled efforts to end the global TB pandemic by 2030, the goal set by the worldwide community in the United Nations Political Declaration to End Tuberculosis on Sept. 26, 2018.
David Lewinsohn, MD, TB professional and ATS International Health Committee Chair
The ATS, initially founded as the American Sanitorium Association in 1905, and our more than 16,000 worldwide members pledge to continue our work to eliminate TB. In collaboration with the WHO and other partners, we have produced global standards of care and provided technical assistance in executing these standards and other TB treatment, prevention and control techniques in 23 countrie.
Dr. Lewinsohn included, “In the U.S., we advise the Administration and Congress to guarantee that we meet the U.S. commitment to end TB by completely moneying our domestic and international TB programs through USAID, CDC and the Global Fund and TB research study through the National Institutes of Health. We urge Congress to pass the End TB Now Act of 2019, S. 2438, and the Comprehensive TB Elimination Act, S. 834/H. R. 3080.”
ATS President James Beck, MD